ERISA Suit Over Zepbound Coverage For Apnea Mostly Survives Dismissal

( April 14, 2026, 11:29 AM EDT) -- INDIANAPOLIS — A health insurance plan participant who invoked the Employee Retirement Income Security Act in a putative class action seeking to get the prescription drug Zepbound covered as a treatment for her obstructive sleep apnea (OSA) mostly prevailed over dismissal motions, with an Indiana federal judge trimming one claim but otherwise allowing the suit against the plan administrator and its parent company to proceed....

Attached Documents

Related Sections